A detailed history of Ubs Group Ag transactions in Optimize Rx Corp stock. As of the latest transaction made, Ubs Group Ag holds 15,936 shares of OPRX stock, worth $159,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,936
Previous 14,826 7.49%
Holding current value
$159,360
Previous $212,000 8.96%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$11.47 - $16.17 $12,731 - $17,948
1,110 Added 7.49%
15,936 $193,000
Q4 2023

Feb 09, 2024

BUY
$7.06 - $14.49 $43,927 - $90,156
6,222 Added 72.32%
14,826 $212,000
Q3 2023

Nov 09, 2023

SELL
$7.43 - $14.96 $7,355 - $14,810
-990 Reduced 10.32%
8,604 $66,000
Q2 2023

Aug 11, 2023

BUY
$11.63 - $15.63 $53,823 - $72,335
4,628 Added 93.19%
9,594 $137,000
Q1 2023

May 12, 2023

SELL
$12.54 - $19.38 $3,837 - $5,930
-306 Reduced 5.8%
4,966 $72,000
Q4 2022

Feb 08, 2023

BUY
$13.77 - $22.04 $45,096 - $72,181
3,275 Added 164.0%
5,272 $88,000
Q3 2022

Nov 10, 2022

BUY
$13.74 - $30.13 $20,403 - $44,743
1,485 Added 290.04%
1,997 $29,000
Q2 2022

Aug 10, 2022

SELL
$21.94 - $40.49 $410,102 - $756,839
-18,692 Reduced 97.33%
512 $14,000
Q1 2022

May 16, 2022

BUY
$35.27 - $62.91 $461,014 - $822,296
13,071 Added 213.13%
19,204 $724,000
Q4 2021

Feb 14, 2022

BUY
$53.57 - $98.0 $118,282 - $216,384
2,208 Added 56.25%
6,133 $381,000
Q3 2021

Nov 15, 2021

SELL
$50.93 - $85.55 $5,856 - $9,838
-115 Reduced 2.85%
3,925 $336,000
Q2 2021

Aug 13, 2021

BUY
$42.76 - $63.33 $114,853 - $170,104
2,686 Added 198.38%
4,040 $250,000
Q1 2021

May 12, 2021

SELL
$33.36 - $62.2 $74,192 - $138,332
-2,224 Reduced 62.16%
1,354 $66,000
Q4 2020

Feb 11, 2021

BUY
$19.04 - $33.1 $66,582 - $115,750
3,497 Added 4317.28%
3,578 $111,000
Q3 2020

Nov 12, 2020

SELL
$12.99 - $21.78 $75,160 - $126,019
-5,786 Reduced 98.62%
81 $2,000
Q2 2020

Jul 31, 2020

SELL
$8.34 - $13.69 $22,251 - $36,524
-2,668 Reduced 31.26%
5,867 $76,000
Q1 2020

May 01, 2020

SELL
$6.71 - $11.4 $56,800 - $96,501
-8,465 Reduced 49.79%
8,535 $77,000
Q4 2019

Feb 14, 2020

BUY
$8.8 - $14.08 $38,693 - $61,909
4,397 Added 34.89%
17,000 $175,000
Q3 2019

Nov 14, 2019

BUY
$13.6 - $16.96 $141,997 - $177,079
10,441 Added 482.93%
12,603 $182,000
Q2 2019

Aug 14, 2019

BUY
$10.43 - $16.62 $22,549 - $35,932
2,162 New
2,162 $35,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $180M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.